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Abstract 
BACKGROUND: Non-coding ribonucleotide sequences, including short and long-term ribonucleic acid (RNA) 
molecules, are a major part of the gene expression products, which have recently been identified on a large 
genomic scale. The long non-coding RNAs (lncRNAs) have a length of greater than 200 nucleotides. Only a small 
fraction of the function of lncRNA molecules is known to date. 
METHODS: PubMed, Scopus, Embase, and Google Scholar were searched from January 2000 to May 2018. Based 
on the study inclusion and exclusion criteria and specific keywords, 92 original, relevant, experimental studies with 
moderate bias were selected. LncRNAs were evaluated as a new trend in molecular biology of diseases. 
RESULTS: Our analysis showed that the presently available evidence confirmed that lncRNAs can be a tool for the 
diagnosis and prognosis of many diseases and alternative therapies. 
CONCLUSION: LncRNAs are an emerging field of investigation as they are suggested to regulate key biological 
processes, including cellular proliferation and differentiation, and their aberrant expression is associated with 
many diseases. An improved understanding of the role of lncRNAs in disease would provide valuable information 
about key biological-promoting pathways and might be highly useful for diagnostic, prognostic, and alternative 
therapies assessments. This knowledge might also lead to advancement in the management of disease through 
the development of novel, personalized lncRNAs-based therapies. 
KEYWORDS: Long Non-Coding RNA, Autoimmune Disease, Neurodegenerative Diseases, Cardiovascular Diseases, 
Immune System Diseases 
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Introduction1 
The 20000 gene encodes a protein in the 
human genome, accounting for less than 2% of 
the entire human genome sequence.1 It is very 
important that 90% of the genomes be actively 
transcribed, but they do not have the potential 
to encode protein.2 Each of these sequences 
organizes cell structures, regulates gene 




expression patterns, and ultimately determines 
cell identity and function.3 This non-coding 
transcript can be divided into the two categories 
of short non-coding ribonucleic acids (snRNAs) 
such as microRNA, and long non-coding RNAs 
(lncRNAs). More than 80% of transcripts are in 
the lncRNA cells.4 These RNAs are very similar 
to mRNAs regarding processing and presence of 
polyadenylation signals.5 
LncRNAs have a length of more than 100 to 
200 nucleotides, and their transcription is 
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Research on the lncRNA promoter showed 
that the transcription of this class is regulated 
by the protein-coding RNA transcription 
factors. It is also hypothesized that the 
transcription of lncRNAs complies with the 
same rules in coding-RNA transcription, and 
the processing involves the capping, 
polyadenylation, and alternative splicing.9 
LncRNAs have recently been identified on a 
massive genomic scale, and only a small part 
of their function is known. By analyzing the 
human genome, it is estimated that there are 
about 23,000 lncRNAs that is greater than the 
number of mRNAs, and this is comparable to 
protein-encoding RNAs.10 LncRNAs sequences 
have encompassed about 90% of the human 
genome and spread throughout the genome.11 
Studies have shown that lncRNAs act as a 
mediator between DNA and proteins, and play 
an important role in cellular function.2 
Currently, lncRNAs have emerged as 
fundamental approaches to biology. Several 
common features among lncRNAs, which 
support their independence and biological 
significance, include the following12:1) Genes 
encoding lncRNAs a) have epigenetic symptoms 
compatible with a transcriptional gene (H3K4me3 
in the promoter gene, H3K36me3 all over the 
gene length), b) are transcribed through the RNA 
polymerase II enzyme, c) are under the regulation 
of well-defined transcription factors, and d) are 
expressed in abundance and a special texture. 2) 
Transcripts for lncRNAs a) often undergo 
polyadenylation, and b) are undergoing 
processing through their conventional processing 
location motifs. Moreover, studies have shown 
that the inappropriate expression of lncRNAs can 
cause various disorders and diseases, and 
lncRNAs are directly linked to several human 
diseases such as various cancers,13 
neurodegenerative disease, autoimmune disease, 
and inflammatory disease.14 In this review article, 
we aimed to investigate the biology of lncRNAs 
and their role in human diseases. 
Materials and Methods 
PubMed, Scopus, Embase, and Google Scholar 
were searched from January 2000 to May 2018. 
Based on the inclusion and exclusion criteria 
and specific keywords, such as long non-
coding RNA, autoimmune disease, 
neurodegenerative disease, cardiovascular 
disease, and immunological disease, 92 
original, relevant experimental studies, which 
were written in English with moderate bias, 
were selected. LncRNAs were evaluated as a 
new trend in molecular biology of diseases. 
Types of LncRNAs: The types of lncRNAs in 
terms of transcription and genetic location are 
classified into the 5 categories of sense, 
antisense, intronic, intergenic, and 
bidirectional. In the sense category, the 
transcription of lncRNAs takes place in a 
single-gene expression of exons. In the 
antisense category, the transcription of 
lncRNAs is performed from the opposite field 
exons in a gene. In the intronic category, the 
intron of a transcriptional gene is carried out. 
The intergenic lncRNAs are independent and 
are located between two other genes. The 
bidirectional lncRNA has a common promoter 
with another gene, but is transcribed in the 
opposite direction.15 Based on this specific 
classification, the study of lncRNA subunits 
can help identify potential functional 
relationships between lncRNAs and the related 
protein-associated genes. 
The biological evolution of lncRNAs: The 
lncRNA sequences, in contrast to their rapid 
biological evolution, display obvious and weak 
indications of natural selection.16 Contrary to 
protein-coding genes, which are the result of 
all or part of the doubling of a sequence and 
diversity, many lncRNAs exhibit a low degree 
of evolutionary pressure and have different 
evolution with the coding genes.17 There are 
different sources for the appearance of 
lncRNAs.17,18 Chromosome rearrangements 
can produce lncRNAs from sequences that 
were not previously transcribed. The collapse 
of the protein-coding gene framework can 
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sequences.16 The non-coding RNAs 
retrotransposition during the duplicate process 
can produce a reverse transcriptional gene or a 
false pseudogene. Local sequential repeat 
sequences may also create a new lncRNAs.This 
phenomenon is seen in the '5' X-inactive 
specific transcript (Xist). The insertion of a 
moving element can also produce lncRNAs 
such as a cytoplasmic RNA of 200 nucleotides 
(brain cytoplasmic 200-nucleotide or BC200). 
Unlike mRNA and many non-coding RNA 
classes, mammalian lncRNAs lack the known 
orthogonal species in non-mammalian species. 
The only exception, in this case, is that the 
RNA contains telomeric repeats (Terra) 
maintained between human and yeast.19 Only 
about 12% of lncRNAs of mice and humans are 
preserved in other species.20 
Biology of lncRNAs: Like other non-coding 
RNA genes, lncRNA genes lack specific 
structural indices. The lncRNA genes are 
usually shorter than protein-coding genes and 
have fewer exons than they have.21-23 
Transcription regulation and chromatin 
alteration patterns of lncRNA genes are similar 
to those of encoding proteins. The processing 
signal of the lncRNA molecules, although 
sometimes performed at a lower processing 
efficiency, is similar to that of the transcription 
codons of protein-coding genes.23,24 Repetitive 
elements have also been reported in lncRNAs, 
which assist in the interaction with their family 
members in other RNAs and play an essential 
role in the lncRNA performance mechanism.25 
The main part of the lncRNA molecules are 
polyadenylate, but sometimes their 3՛ end is 
seen in another form. In humans, there are 
about 80 lncRNAs with circular isoforms.26 A 
little of lncRNAs, due to the formation of a 
three-spiral structure at the end of the 3', and 
some of others by snoRNA molecules at both 5' 
and 3' ends are stable.27,28 
LncRNAs have an openreading frame 
(ORF) without coding the protein, but when 
lncRNAs come along with the ribosome in the 
cytoplasm, other ORFs of these molecules may 
play the role of mRNA metabolism.29 Frame 
reading open upstream of lncRNA genes plays 
an important role in regulating the expression 
and stability of lncRNA molecules.30,31 The 
lncRNAs can be translated in a way that the 
transcribed lncRNAs from the downstream are 
protected from the ribosomal scan and can 
freely perform their function in the cytoplasm 
without interfering with the ribosomes. 
LncRNAs may also direct agents to the 
ribosomal or modulate the stability of 
lncRNAs by affecting the pathways of RNA 
degradation.32 LncRNAs are preferably in the 
nucleus, can also be seen in the cytoplasm, and 
are expressed in specific cells and at low levels. 
LncRNAs can express the gene through 
alternative splicing, transcription, and post-
transcription.33 The transcription of lncRNAs 
takes place between the encoding genes and 
often from the opposite DNA strand.34 
The shape and second form of lncRNAs: The 
formation of a secondary structure is of 
particular importance for lncRNAs.35 The rate 
of formation of the secondary structure 
coincides with the expression level of 
lncRNAs, in such a way that more organized, 
more stable lncRNAs, and therefore, lower 
expressions are observed. Higher C/G content 
is also associated with greater organization, 
higher stability, and lower expression of 
lncRNAs.36 The prediction of secondary stem-
ring structures is useful in identifying lncRNA 
function. Mfold software, which is widely 
used, is designed to predict the secondary 
structure of RNA.37 For this purpose, newer 
programs, such as CompaRNA, have been 
developed.38,39 Studies have uncovered the 
many functions of lncRNAs and their strategic 
roles in the advancement and development of 
intracellular pathways. The pattern suggested 
by these studies indicates that the performance 
characteristics of lncRNAs may be due to their 
unique structure in bringing together specific 
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proteins and tissue-specific RNAs, and the 
subsequent interactions with these DNAs.40 
The mechanisms of lncRNAs function: 
Various research methods have been 
developed to uncover the functional and 
molecular mechanisms of lncRNAs. The most 
efficient approaches to discovering the 
function of lncRNAs include high-performance 
lncRNA expression analysis, obtained data 
validation, and lncRNA-protein interactions 
evaluation. All of these approaches are 
possible with special laboratory processes.41 
Studies on the role of lncRNAs in the 
regulation of the gene expression pattern 
indicate the complexity of their control 
mechanism; these molecules are involved in 
different levels of gene expression regulation, 
including regulation at the transcriptional level 
and after transcription. Regulation at the 
transcription level involves the role of 
lncRNAs in the epigenetic inactivation of some 
genes. However, regulatory levels after 
transcription, which are affected by the action 
of lncRNAs, include42 mRNA degradation 
protection, pre-mRNAs processing, translation‎ 
suppression, ‎acceleration of mRNA 
degradation, mRNA translation activation, and 
collaboration with microRNAs‎. The protection 
of mRNA from degradation by miRNAs in 
antisense lncRNAs is achieved through these 
lncRNAs forming a hybrid with the mRNA 
molecule. Pre-mRNAs processing involves the 
competing of some lncRNAs with mRNA in 
binding to the process regulator proteins, and 
thus, affecting the mRNA values of the mature 
cell in the cell. Translation suppression is 
achieved through the imperfect interference of 
lncRNAs with the mRNA and invoking of the 
translation inhibitors. 4) The degradation of 
specific mRNAs is accelerated through the 
cooperation of some lncRNAs with other 
mRNA degrading proteins. The mRNA 
translation activation has been observed in 
some antisense lncRNAs; these lncRNAs are 
part of their structure that perfectly 
complements the end of the '5 mRNA 
molecule. They attach to the mRNA, stabilize 
it, and help call the ribosomes to the mRNA. 
The result of such an approach is increase in 
translation. Moreover, some of the lincRNAs 
act in the same direction (in collaboration 
with) or reverse to the activity of the 
microRNA molecules, and thus, play a 
prominent role in activating or inhibiting the 
expression of the gene.43 
A theory was proposed by Wang and 
Chang, which showed different modes of gene 
expression regulation by lncRNAs. According 
to this theory, lncRNAs are influenced by gene 
expression through four mechanisms, which 
are described in the following section. This 
division was also proposed by Perin ‎et al.44 
Typically, many of the lncRNAs can be 
performed by a set of these processes. These 
mechanisms include splicing‎, decoy, guide,‎ 
and scaffold‎.‎ In splicing, some of the lncRNAs 
are used to stimulate a cell through a method, 
such as cellular stress and temperature change, 
along with growth factors, in order to activate 
a gene. In decoy, a number of lncRNAs bind to 
transcription factors preventing the binding of 
these factors to the gene, and thus, prevent the 
transcription and inhibit the gene. In the guide 
mechanism, lncRNAs have the ability to bind 
to ribonucleoprotein and cause changes in 
chromatin, and thus, lead to epigenetic 
changes. In the scaffold mechanism, lncRNAs 
aggregate the protein complex and bind to  
the target gene, causing changes in the 
chromatin structure and transcription to the 
inhibitor or activation. 
LncRNA–DNA interactions: Approximately, 
all the lncRNAs mentioned so far act by 
regulating the transcription of target genomic 
locus in cis- (nearby genes) or trans- (distant 
genes) acting manner through binding to the 
target DNA by identification of specific 
chromatin structures or as an RNA–DNA 
heteroduplex or RNA–DNA DNA triplex. 
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single-stranded DNA by Watson-Crick base 
pairs (duplex) or can interact with double-
stranded DNA by inserting into the major 
groove of the double helix DNA structure with 
sequence specificity (triplex).45 Previously, it 
has been reported that lncRNAs can form a 
stable duplex with promoter sequences46 or 
can form a triplex structure at ribosomal RNA 
promoters in fibroblasts.47 Local chromatin 
changes can result from the transcription of 
lncRNAs that are not induced by the non-
coding transcript.48-50 In a study, the 
mechanisms of local gene regulation by twelve 
lncRNAs were evaluated five of which 
regulate the expression of their neighboring 
genes in a cis-acting manner. Surprisingly, none 
of the five cis-regulators required the lncRNAs 
transcripts themselves, but this procedure 
depended on lncRNAs transcription processes 
such as lncRNA promoters enhancer activity, 
transcription, or splicing of the lncRNA.50 
LncRNA–RNA interactions: Numerous 
classes of lncRNAs act by RNA–RNA 
interactions. For example, the Epstein-Barr 
virus (EBV) non-coding RNAs (EBER2) form 
base pairs with nascent transcripts of the locus 
from the latent EBV genome and recruit the 
PAX5 transcription factor to the terminal 
repeats. Recruitment of PAX5 transcription 
factor regulates the expression of nearby genes 
to the TRs, and thereby, regulates the lytic 
replication cycle of EBV.51 A major mechanism 
of gene expression modulation in circRNAs is 
RNA binding. Until now, studies have 
indicated two functional consequences of 
RNA–RNA binding via circRNAs. The first is a 
reduction in the availability of partner RNA 
transcripts through direct base pairing, in 
particularly, with microRNAs. The second 
consequence is a reduction in alternative RNA 
transcription by competition for transcriptional 
machinery components. As „sponges‟ for 
microRNA, circular RNAs can efficiently 
„titrate‟ microRNA from its functional target 
genes. For example, the ciRS-7 includes 70 sites 
for miR-7 binding which controls mid-brain 
development through „titrating‟ of miR-7 
transcripts.26,52 CiRS-7 is fully resistant to target 
destabilization mediated by miR-7, so it 
intensely suppresses the miR-7 function, which 
leads to an increased number of miR-7‟s 
targets. Similarly, the Sry circRNAs, a circRNA 
in testis, act as a sponge for miR-138.52 
Generally, the lack of 5′ phosphate and 3′ OH 
ends in circRNAs results in more stability than 
that of linear RNAs and this proposes that long 
non-coding RNAs can temporally modulate the 
gene expression via base-pairing interactions 
and modification of their secondary structures. 
Controlling the destruction of mRNA 
molecules: The frequency of mRNA has a 
direct correlation with protein output, and 
factors affecting this frequency play their role 
through the effect of the transcriptional mRNA 
and its degradation rate. The mRNA can be 
decomposed through various processes during 
transcription or after the completion of 
transcription. One of these processes is the 
STAU1-mediated decay of the STAU1 agent by 
mRNA, which results in the decomposition of 
active mRNAs. The formation of the open pair 
between the Alu elements in lncRNAs and the 
Alu elements in the UTR'3 of the STAU1 target 
mRNA molecule causes the formation of 
STAU1 binding sites. This event is associated 
with the activation of the STAU1 agent and its 
attachment to the mRNA. This finding 
uncovers a new approach to invoking proteins 
to mRNA, and to decompressing mRNA 
through them.53 
Controlling of gene expression: LncRNAs 
are commonly expressed at low levels, retain 
little consensus among species, and often 
display specific tissue/specific expression 
patterns of the cell.21,32 
LncRNAs have different effects on gene 
expression. One of the first functions identified 
in lncRNAs is the variation in gene expression 
by alteration of the chromatin structure. In 
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identified with different roles in gene 
expression. Human lncRNAs participate in a 
range of biological processes, including 
epigenetics, alternative splicing, and RNA 
destruction and translation.17 Furthermore, the 
role of lncRNAs has been shown to disable 
chromosome X and genetic imprinting as well 
as growth and differentiation.54 
Studies have shown that lncRNAs are also 
involved in protein translation. For example, 
an antisense lncRNAs for quinine-carboxy-
terminal hydrolyzate (UCHL1-AS) mRNA can 
enhance mRNA stability and increase UCHL1 
protein synthesis. This activity is dependent on 
the presence of a SINEB2 containing 
replication.55 Beta-secretase-1 antisense 
(BACE1-AS) is a natural antisense transcript 
for BACE1 mRNA (Beta positioning enzyme in 
amyloid precursor protein), which is 
associated with mRNA stability and increased 
BACE1 protein levels.56 
Epigenetic functions: The epigenetic 
concept was first introduced by Waddington 
Conrad in 1942 as a theme for expanding 
evolutionary and developmental programs 
and processes related to an undifferentiated 
egg, including complete cleansing and re-
projection at a point in the cellular cycle. 
Although this perception remains valid, the 
term “epigenetic”, in its current application, 
includes inherited gene expression changes 
that do not result from genetic code key 
differences. Epigenetics is defined as stable 
and inherited changes in the chromatin 
structure and is different from the 
phenomenon of mutation that occurs at the 
DNA sequence level. Epigenetic events, by 
changing and modifying the pattern of 
euchromatin to heterochromatin, and vice 
versa, regulate the expression of multiple 
genes. The most important of these events may 
include the methylation of some of the 
cytosine openings in the CpG dinucleotides 
(particularly near the promoter of some genes), 
as well as the reactions of methylation, 
acetylation, and other changes on histones.57 
Many lncRNAs have diverse epigenetic 
activities. Some lncRNAs can interact with 
chromatin-altering enzymes and cause 
changes in the transcriptional activity of some 
of the genes, or some other extinction.58 
Xist, including the best-known lncRNAs, is 
responsible for initiating and extending the 
inactivation of chromosome X in somatic cells 
in women.59 It is thought to be necessary to 
silence hundreds of genes based on 
chromosome X.Xist, which has a small repeat 
region called RepA, and is transcribed from both 
chromosomes X.60 Tsix is another antisense of the 
RepA sequence, and it attaches to this sequence 
in the Xist transcript of one of the chromosomes 
X. This prevents the Xist from binding to its 
chromosome X, which is associated with active 
chromosome X activation. In the next step, 
another Xist transcript containing RepA is  
free, with polycomb repressive complex 2 set to  
a chromatin-modifying complex in the X-
inactivation center of the other chromosome X, 
causing it to be deactivated.60 Moreover, Tsix 
apply their regulatory function to a portion of 
the chromatin adjacent to their coding gene. 
This type of regulation is called the cis type. 
Another epigenetic event, in which the 
expression of the gene is responsible for 
lncRNAs, is a genomic role.61 The expression of 
the implanted genes depends on their parent 
origin, and the differential expression level 
between the two involved alleles can vary 
from gene to gene. Because of the role played 
by genes in the development of mammals, 
their expression should be carefully 
regulated.62 In a study by Rinn et al., another 
lncRNA called HOTAIR was discovered that 
regulates the expression of human HOX genes 
trans.63 Subsequent studies showed that 
HOTAIR regulates the expression of the gene 
in the form of trans in conjunction with 
chromatin-modifying sets, including PRC2, 
LSD1, and COREST/REST.63-65 HOTAIR serves 
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these collections to their intrinsic target genes. 
COREST/LSD1 sets up lysine 4 from histone 
H3, and PRC2 performs methylation of lysine 
27 from histone H3. These events are 
associated with the inactivation of the 
HOTAIR target genes.65 HOTAIR was one of 
the first lncRNAs to be known to play a critical 
role in the epigenetic regulation of cancer.66 
34a-miR is a kind of microRNA that can 
decrease the HOTAIR stability; this process 
plays a role in the development of prostate 
cancer.67 It can be emphasized that many of the 
role-bearing sites have an expression, and code 
the lncRNAs that play a major role in 
regulating the adjacent protein-encoding genes 
in the form of cis.68 ANRIL is also a lncRNA 
identified in 2013, and its coding site is located 
on the 9p21 chromosomal bar. This site is 
considered as a hotspot for multidisciplinary 
diseases and is associated with cardiovascular 
disease (CVD), cancers, diabetes, glaucoma, 
and endometriosis. It has been determined that 
ANRIL regulates the expression of its adjacent 
gene, B/CDKN2A, using epigenetic 
mechanisms and via polycambotic proteins as 
cis, and therefore, plays a significant role in 
controlling the proliferation and aging of the 
cell.69 Other roles of lncRNAs in post-
transcription expression control include 
regulating the intermittent processing, 
maintaining the state of pluripotency, and 
controlling the flow of molecules between the 
nucleus and the cytoplasm discussed below. 
Role in the alternating processing 
mechanism: Since a single mRNA may be 
constructed of several proteins with non-
tangled functions, intermittent processing of 
pre-mRNA increases the complexity of the 
proteome in the cells. For the first time in 
connection with metastasis, a lncRNAs plays a 
critical role in the pre-mRNA intermittent 
processing. MALAT1 is in the nucleus speckle, 
which involves several proteins involved in 
the intermittent processing of mRNAs. It 
seems that MALAT1 provides a molecular 
scaffold for the function of these proteins. 
MALAT1 also regulates the phosphorylation 
of SR proteins. SR proteins are 
serine/threonine-rich proteins involved in the 
regulation and selection of processing sites in 
pre-mRNAs. MALAT1 can regulate the level of 
the SR proteins by regulating the 
phosphorylation of SR proteins, thereby 
influencing the processing of many pre-
mRNAs.70 This lncRNA target is a microRNA-
Ago2-RISC complex, and the extinction of 
Ago2 expression results in the formation of 
constant levels of MALAT1 in the cell. An 
increase in the expression of 9-miR is also 
associated with a decrease in the level of this 
lncRNA in the cell.71 
The role of lncRNAs in diseases 
Cancer: A lncRNA was identified in lncRNA-
ATB in 2014, which was activated via the TGF-
β messenger pathway and adjusted several 
stages of the hepatocellular carcinoma 
metastasis process through two independent 
mechanisms. In the first mechanism, this 
transcript acts as a ceRNA, and by arresting 
members of the miR200 family, it reduces their 
access to their transcripts. This event induces 
the expression of another lncRNA called 
2Zeb1, which increases its values by 
decreasing E-cadherin, followed by a change 
from epithelial to mesenchymal state and 
increased metastasis. In the second 
mechanism, lncRNA-ATB binds to IL-11 
mRNA and increases its stability. Increase in 
the levels of IL-11 by lncRNA-ATB activates 
the STAT3 molecule. This is associated with an 
increase in the intrinsic tendency of cells to 
survive and their success in the formation of a 
colony in new tissue. The expression of 
lncRNA-ATB is a valid predictor of the 
incidence or non-recurrence of disease and 
estimates of the overall survival rate in 
patients with hepatocellular carcinoma.72 
LncRNA-EPS is one of the types of lncRNAs 
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final differentiation of the types of blood cells. 
Silencing this lncRNA prevents the 
differentiation of blood cells and induces 
apoptosis in them. At the same time, its 
aberrant expression is associated with 
inhibition of apoptosis in blood cells. 
LincRNA-EPS is capable of suppressing the 
expression of a pro-apoptotic gene called 
Pycard, and thus, the inhibition of 
apoptosis.73,74 High levels of Pycard inhibit the 
proliferation of blood cells and induce 
apoptosis or differentiation in these cells.75 
DiGeorge syndrome: DiGeorge syndrome is 
a heterogeneous disorder characterized by 
evolutionary deformity, cognitive and 
behavioral disorders, and an increased risk of 
psychiatric disorders. This syndrome is caused 
by the removal of the chromosomal region 
22q11.2. This region encodes a REST regulated 
lncRNA called DGCR4, which indicates the 
potential role of this lncRNA in regulating 
neural evolution and the phenotype of the 
disorder.76 
Cardiovascular Disease: Antisense non-
coding RNA in the INK4 locus is indicated as 
a risk factor for CVD.77,78 Myocardial 
infarction associated transcript (MIAT) is 
related to MI.79 As yet, the studies of 
circulating lncRNAs serving as cardiac 
biomarkers make less progress due to the 
instabilities of lncRNAs in body fluids as 
usually expected. Long intergenic non-coding 
RNA predicts cardiac remodeling (LIPCAR), 
is well known as a mitochondrial lncRNAs, is 
related with cardiac remodeling and chronic 
heart failure, and is suggested to be a 
potential cardiac biomarker.80 
Multiple sclerosis: Multiple sclerosis (MS) is a 
complex autoimmune disease, and recent 
immunological studies have demonstrated 
abnormal activity of cluster of differentiation 8 
(CD8+)  T cells in the pathology of MS.81 Because 
lncRNAs are involved in the differentiation and 
activity of CD8-T cells, they may be important in 
MS development and progression. LncRNAs 
derived from the promoter of the T cell chain of α 
are responsible for regulating the use of 
downstream genes, and thus, the production of 
various T cell receptors.82 In recent studies, 
researchers have found that the locus associated 
with the α interleukin-2 receptor is code-labeled 
with some lncRNAs, one of which, called M21981, 
greatly increases with T cell activity. It is 
important to note that this locus is associated with 
MS talent.83 Tmevpg1 is another lncRNA that 
may interfere with MS. This lncRNA is 
transcribed in human and mouse immune cells 
from a cluster of cytokine genes that includes 
interferon γ84. Tmevpg1 is believed to be involved 
in controlling TME infection sustainability.84 TME 
infection is used as a laboratory model for MS 
because it is characterized by chronic 
inflammatory demyelination associated with 
apoptotic oligodendrocytes and axonal 
degeneration.85 These observations suggest that 
lncRNAs can be responsible for regulating CNS 
immune responses. 
The role of lncRNAs as diagnostic and 
prognostic factors: The discovery that 
lncRNAs are key regulators of diseases, 
including cancer and its progression, have 
been associated with prospects for the use of 
these molecules as diagnostic and therapeutic 
targets. The expression of many lncRNAs such 
as ANRIL, HOTAIR, and MALAT-1 is limited 
to specific tissue and a specific disease, and can 
be used as prognostic markers. The number of 
lncRNAs used as biochemical markers for 
diagnosis and prognosis is increasing, and 
some have been approved for clinical use.86 
One of the main advantages of lncRNAs is 
their high stability and their presence in body 
fluids, especially when exposed to 
nanoparticles such as exosomes and apoptotic 
body.87 Therefore, they can be measured by 
blood, urine, or saliva sampling, and then, 
using the Real-Time polymerase chain reaction 
(PCR) method.86-88 Some lncRNAs can act as a 
diagnostic agent or as a prognostic factor. For 
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antigen 3 (PCA3) is associated with prostate 
cancer to a large extent, and is commonly used 
to determine the risk of prostate cancer from 
urine specimens and avoid unnecessary 
prostate biopsy.89 All lncRNAs, with a 
determining role in diagnosis and prognosis, 
affect the cell cycle processes that create a 
specific phenotype, such as proliferation, 
invasion, and survival.90-92 
Conclusion 
LncRNAs are non-coding transcripts of protein 
that interact with other molecules through 
their molecular structure and have vital roles 
in controlling different types of cellular 
processes, such as growth, division, and cell 
differentiation. Furthermore, lncRNAs have a 
role in different human diseases and their 
dysregulation cause viral disease. Therefore, 
lncRNAs have a potential application as a 
biomarker for screening, diagnosis, prognosis, 
treatment response prediction, and treatment 
evaluation. By increasing the trend in studying 
lncRNAs, gradually a deeper understanding of 
these molecules is achieved. 
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